Healthy Skepticism Library item: 4945

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Small DH.
Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer's disease: do we need new inhibitors?
Expert Opin Emerg Drugs 2005 Nov 01; 10:(4):817-25
http://www.ncbi.nlm.nih.gov/pubmed/16262564

Abstract:

Acetylcholinesterase inhibitors (AChEIs) have been shown to produce a small, but significant, improvement in cognition in patients with Alzheimer’s disease. However, not all patients respond equally, and cognitive benefit may be of limited duration. Although new AChEIs continue to be developed, more recent studies have been aimed at developing inhibitors that have additional actions separate from AChE inhibition. Importantly, new treatments that target the underlying pathogenic mechanism of Alzheimer’s disease (statins, secretase inhibitors, vaccination) may eventually emerge. These new treatments could make AChEI therapy less relevant for treatment of Alzheimer’s disease

Keywords:
Alzheimer Disease/drug therapy* Alzheimer Disease/enzymology* Animals Cholinesterase Inhibitors/chemistry Cholinesterase Inhibitors/therapeutic use* Clinical Trials/statistics & numerical data Clinical Trials/trends Dementia/drug therapy Dementia/enzymology Drug Industry/trends Drugs, Investigational/chemistry Drugs, Investigational/therapeutic use* Humans